The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

Recruiting Phase 2 Interventional Study
Smoking
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 75
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Prevention
Participants needed
76 (estimated)
Sponsor
University of Florida · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will evaluate the compliance with a daily kava regimen among active smokers who have an intention to quit smoking. This study will also investigate whether kava use can facilitate tobacco cessation, reduce stress, and improve sleep.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * adults aged 21 years or above (legal age for smoking in the U.S.) up to 75 years old; * self-reported smoking at least 5 cigarettes/day for the past year with INTENTION to quit at time of screening visit; * expired carbon monoxide level of more than 8 ppm at recruitment; * wil…
Contacts

Ramzi G Dr. Salloum

352-294-4997

rsalloum@ufl.edu

CONTACT

Chengguo Dr. Xing

352-294-8511

chengguoxing@cop.ufl.edu

CONTACT